Top
Press Releases / Notices2022

Press Releases / Notices

The company’s press releases sometimes carry information on pharmaceutical drugs and products in the pipeline. Under no circumstances is such information provided to promote or advertise these products or offer medical advice.

by Year

2022
2021
2020
2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009

by Category

Corporate
Management & Finance
Pharmaceuticals
R & D
Sustainability
Food Business
Other
Notices

NEWS 2022

May 17, 2022 Corporate PDF241 KB

Nippon Shinyaku Provides Assistance to Ukraine
May 11, 2022 Management & Finance

Outline of Consolidated Financial Results for the Year Ended March 31, 2022
March 28, 2022 Pharmaceuticals PDF285 KB

Marketing approval of MonoVer for I.V. injection 500mg/1000mg by MHLW for the treatment of iron deficiency anemia
March 17, 2022 R & D PDF260 KB

The result of an Investigator-Initiated Clinical Trial (First In Human trial) of NS-089/NCNP-02 for the treatment of Duchenne muscular dystrophy
March 11, 2022 R & D PDF259 KB

The result of an Investigator-Initiated Clinical Trial (First In Human trial) of NS-089/NCNP-02 for the treatment of Duchenne muscular dystrophy
March 07, 2022 Pharmaceuticals PDF338 KB

Filing of Humanized Anti-CD20 Monoclonal Antibody Gazyva for Additional Indication of Chronic Lymphocytic Leukemia
February 10, 2022 Management & Finance PDF547 KB

Outline of Consolidated Financial Results for the Third Quarter Ended December 31, 2021
February 10, 2022 Notices PDF1.1 MB

Presentation Material for IR Meeting
January 26, 2022 Corporate PDF270 KB

Nippon Shinyaku Establishes a Local Subsidiary in Tianjin, China
January 25, 2022 Pharmaceuticals PDF245 KB

Nippon Shinyaku and Capricor Therapeutics enter into an Exclusive Partnership for Commercialization and Distribution of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy in US

by Year

2022
2021
2020
2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009

by Category

Corporate
Management & Finance
Pharmaceuticals
R & D
Sustainability
Food Business
Other
Notices

Top
PressReleases / Notice2022